| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| S Cohen |
What Price Morning Glory? |
Mind |
1964 |
| Cohen S |
A classification of LSD complications |
Psychosomatics |
1966 |
| Geiger RS, Rothman A, Sus... |
LSD effects on mature and immature brain cells in culture |
Fed. Proc. |
1968 |
| Eisner, BG |
The Group as Means and Matrix for Change |
Symposium Paper: On ... |
1971 |
| Guha D, Pradhan SN |
Mescaline |
PharmChem Newsletter |
1972 |
| Young RE, Milroy R, Hutch... |
The Rising Price Of Mushrooms |
The Lancet |
1982 |
| Renfroe CL, Messinger TA |
Street drug analysis: an eleven year perspective on illicit drug alter... |
Semin Adolesc Med |
1985 |
| Charney DS, Goodman WK, P... |
Serotonin function in obsessive-compulsive disorder A comparison of th... |
Arch Gen Psychiatry |
1988 |
| Price LH, Ricaurte GA, Kr... |
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-m... |
Arch Gen Psychiatry |
1989 |
| Price LH, Ricaurte GA, Kr... |
Responses to I.V. L-tryptophan in MDMA Users |
NIDA Res Monogr |
1989 |
| Olney JW, Labruyere J, Pr... |
Pathological changes induced in cerebrocortical neurons by phencyclidi... |
Science |
1989 |
| Grob C, Bravo G, Walsh R |
Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxic... |
Arch Gen Psychiatry |
1990 |
| Olney JW, Labruyere J, Wa... |
NMDA antagonist neurotoxicity: mechanism and prevention |
Science |
1991 |
| Kosten TR, Price LH |
Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use [C... |
Journal of Nervous &... |
1992 |
| Krystal JH, Price LH, Ops... |
Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood ... |
Am J Drug Alcohol Ab... |
1992 |
| Schifano F, Magni G |
MDMA ('ecstasy') abuse: psychopathological features and craving for ch... |
Biol Psychiatry |
1994 |
| Edwards JG, Anderson I |
Systematic review and guide to selection of selective serotonin reupta... |
Drugs |
1999 |
| Montoya AG, Sorrentino R,... |
Long-Term Neuropsychiatric Consequences of 'Ecstasy' (MDMA): A Review |
Harv Rev Psychiatry |
2002 |
| Goldberger BA, Frost-Pine... |
Ecstasy Deaths in the State of Florida: A Post-Mortem Analysis |
Biol Psych |
2002 |
| Wilkins C, Bhatta K, Pled... |
Ecstasy use in New Zealand: findings from the 1998 and 2001 National D... |
N Z Med J |
2003 |
| Uchiyama N, Kikura-Hanaji... |
[Analysis of designer drugs detected in the products purchased in fisc... |
Yakugaku Zasshi |
2008 |
| Yohannan JC, Bozenko JS |
The Characterization of 3,4-Methylenedioxypyrovalerone (MDPV) |
Microgram Journal |
2010 |
| Brandt SD, Sumnall HR, Me... |
Analyses of second-generation 'legal highs' in the UK: Initial finding... |
Drug Test Anal |
2010 |
| Winstock A, Mitcheson L, ... |
Mephedrone: still available and twice the price |
Lancet |
2010 |
| Durham M |
Ivory wave: the next mephedrone? |
Emerg Med J |
2011 |
| Carhart-Harris RL, King L... |
A web-based survey on mephedrone |
Drug Alcohol Depend |
2011 |
| Antonowicz JL, Metzger AK... |
Paranoid psychosis induced by consumption of methylenedioxypyrovaleron... |
Gen Hosp Psychiatry |
2011 |
| Editors |
Emergency department visits after use of a drug sold as 'bath salts'--... |
MMWR Morb Mortal Wkl... |
2011 |
| Spiller HA, Ryan ML, West... |
Clinical experience with and analytical confirmation of 'bath salts' a... |
Clin Toxicol (Phila) |
2011 |
| Penders TM, Gestring R |
Hallucinatory delirium following use of MDPV: 'Bath Salts' |
Gen Hosp Psychiatry |
2011 |
| Editors |
Legal Drugs of Abuse |
Emerg Med Rep |
2011 |
| Coppola M, Mondola R |
3,4-Methylenedioxypyrovalerone (MDPV): Chemistry, pharmacology and tox... |
Toxicol Lett |
2011 |
| Reitzel LA, Dalsgaard PW,... |
Identification of ten new designer drugs by GC-MS, UPLC-QTOF-MS, and N... |
Drug Test Anal |
2011 |
| Kyle PB, Iverson RB, Gaja... |
Illicit bath salts: not for bathing |
J Miss State Med Ass... |
2011 |
| Rosenbaum CD, Carreiro SP... |
Here Today, Gone Tomorrow...and Back Again? A Review of Herbal Marijua... |
J Med Toxicol |
2012 |
| Van Hout MC, Bingham T |
'A Costly Turn On': Patterns of use and perceived consequences of meph... |
Int J Drug Policy |
2012 |
| Fass JA, Fass AD, Garcia ... |
Synthetic Cathinones (Bath Salts): Legal Status and Patterns of Abuse ... |
Ann Pharmacother |
2012 |
| Olives TD, Orozco BS, Ste... |
Bath salts: the ivory wave of trouble |
West J Emerg Med |
2012 |
| Murray BL, Murphy CM, Beu... |
Death following recreational use of designer drug 'bath salts' contain... |
J Med Toxicol |
2012 |
| Prosser JM, Nelson LS |
The Toxicology of Bath Salts: A Review of Synthetic Cathinones |
J Med Toxicol |
2012 |
| Coppola M, Mondola R |
Synthetic cathinones: Chemistry, pharmacology and toxicology of a new ... |
Toxicol Lett |
2012 |
| Jerry J, Collins G, Stree... |
Synthetic legal intoxicating drugs: The emerging 'incense' and 'bath s... |
Cleve Clin J Med |
2012 |
| Thornton SL, Gerona RR, T... |
Psychosis from a Bath Salt Product Containing Flephedrone and MDPV wit... |
J Med Toxicol |
2012 |
| Macher AM, Penders TM |
False-positive phencyclidine immunoassay results caused by 3,4-methyle... |
Drug Test Anal |
2012 |
| Ross EA, Reisfield GM, Wa... |
Psychoactive 'Bath Salts' Intoxication with Methylenedioxypyrovalerone |
Am J Med |
2012 |
| Watterson LR, Kufahl PR, ... |
Potent rewarding and reinforcing effects of the synthetic cathinone 3,... |
Addict Biol |
2012 |
| Cameron KN, Kolanos R, So... |
Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV)... |
Br J Pharmacol |
2012 |
| Simmler LD, Buser TA, Don... |
Pharmacological characterization of designer cathinones in vitro |
Br J Pharmacol |
2013 |
| Cameron K, Kolanos R, Ver... |
Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents o... |
Psychopharmacology (... |
2013 |
| Wyman JF, Lavins ES, Enge... |
Postmortem Tissue Distribution of MDPV Following Lethal Intoxication b... |
J Anal Toxicol |
2013 |
| Baumann MH, Partilla JS, ... |
Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV)... |
Neuropsychopharmacol... |
2013 |
| Fantegrossi WE, Gannon BM... |
In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypy... |
Neuropsychopharmacol... |
2013 |
| Johnson LA, Johnson RL, P... |
Current 'Legal Highs' |
J Emerg Med |
2013 |
| Marinetti LJ, Antonides H... |
Analysis of synthetic cathinones commonly found in bath salts in human... |
J Anal Toxicol |
2013 |
| Merluzzi AP, Hurwitz Z, B... |
Differential Expression of MDPV-Induced Taste Aversions and Thermoregu... |
FASEB Journal |
2013 |
| Simojoki K, Alho H |
A Five-Year Follow-up of Buprenorphine Abuse Potential |
J Alcoholism Drug De... |
2013 |
| Aarde SM, Huang PK, Creeh... |
The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a... |
Neuropharmacology |
2013 |
| Seely KA, Patton AL, Mora... |
Forensic investigation of K2, Spice, and bath salt commercial preparat... |
Forensic Sci Int |
2013 |
| Lawn W, Barratt M, Willia... |
The NBOMe hallucinogenic drug series: Patterns of use, characteristics... |
J Psychopharmacol |
2014 |
| Nizar H, Dargan PI, Wood ... |
Using internet snapshot surveys to enhance our understanding of the av... |
J Med Toxicol |
2015 |
| Armenian P, Thornton S, G... |
Ease of Identifying and Purchasing Popular Research Chemicals via the ... |
NACCT |
2015 |
| Adamowicz P, Gieron J, Gi... |
The prevalence of new psychoactive substances in biological material -... |
Drug Test Anal |
2015 |
| Wojcieszak J, Andrzejczak... |
Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of P... |
Neurotox Res |
2016 |
| Odoardi S, Romolo FS, Str... |
A snapshot on NPS in Italy: Distribution of drugs in seized materials ... |
Forensic Sci Int |
2016 |
| Bade R, Bijlsma L, Sancho... |
Liquid chromatography-tandem mass spectrometry determination of synthe... |
Chemosphere |
2016 |
| van der Gouwe D, Brunt TM... |
Purity, adulteration and price of drugs bought online versus offline i... |
Addiction |
2017 |
| Aldridge J, Stevens A, Ba... |
Will growth in cryptomarket drug buying increase the harms of illicit ... |
Addiction |
2017 |
| Karila L, Lafaye G, Scoca... |
MDPV and α-PVP use in humans: The twisted sisters |
Neuropharmacology |
2017 |
| Moosmann B, Auwärter V |
Designer Benzodiazepines: Another Class of New Psychoactive Substances |
Handb Exp Pharmacol |
2018 |
| Zaami S, Giorgetti R, Pic... |
Synthetic cathinones related fatalities: an update |
Eur Rev Med Pharmaco... |
2018 |
| Abouchedid R, Gilks T, Da... |
Assessment of the Availability, Cost, and Motivations for Use over Tim... |
J Med Toxicol |
2018 |
